INN monograph
Enterotoxigenic E. Coli (Etec) Oral Vaccine
Vaccine / immunological product · POM
Verified · Updated 01 Aug 2026 · Source: Unsourced template; Local active-ingredient clinical extract; Professional class pharmacology (Vaccine / immunological product)
Kenya market
Wholesale / list prices where loaded
Risk first
Contraindications
- Anaphylaxis to prior dose or component.
- Live vaccines contraindicated in significant immunosuppression and usually pregnancy.
- Defer for moderate–severe acute illness.
Precautions
- Observe 15 minutes post-dose if high anaphylaxis concern.
- Correct injection technique and site.
- Report AEFI via national systems.
Point of care
Dosing
Adult
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
Paediatric
Paediatric dosing is weight- and age-based; use a paediatric formulary / SmPC. Do not extrapolate adult tablets without calculation.
Renal
N/A generally.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic
N/A generally.
Safety
Drug interactions
- Follow Kenya KEPI / MoH schedules.
- Never freeze freeze-sensitive vaccines incorrectly.
- Document batch and site.
- Separate true contraindications from precautions.
Safety
Adverse effects
- Local pain, low-grade fever, myalgia.
- Serious: anaphylaxis, vaccine-specific rare events (e.g. intussusception historically with some rotavirus products).
Use
Indications
- Therapeutic use is agent- and indication-specific within the class (Vaccine / immunological product).
- Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.
Pharmacology
Mode of action
Vaccines present antigen to the adaptive immune system to generate protective antibodies and memory cells without causing full disease (or using attenuated/inactivated/subunit/mRNA platforms).
Full mechanism text
Vaccines present antigen to the adaptive immune system to generate protective antibodies and memory cells without causing full disease (or using attenuated/inactivated/subunit/mRNA platforms). Immunoglobulins provide passive temporary immunity.
ADME
Pharmacokinetics & PD
| Onset | Immune response days–weeks |
|---|---|
| Duration | Months–lifelong (schedule-dependent) |
| Route | IM / SC / ORAL / ID |
Kenya
Brands & prices
| Brand | Company | Pack | KES |
|---|---|---|---|
| No brands linked yet. | |||
Special populations
Pregnancy & lactation
Pregnancy
Inactivated vaccines (e.g. influenza, Tdap) often recommended; live vaccines generally avoided.
Lactation
Most vaccines compatible; live vaccines usually fine for breastfeeding mother.
Diet
Food & alcohol
- Food
Trust
Sources & disclaimer
Source: Unsourced template; Local active-ingredient clinical extract; Professional class pharmacology (Vaccine / immunological product)
Last reviewed: 01 Aug 2026
Decision support only — not a substitute for clinical judgment, product SmPC, or Kenya STG/EML.